JCR Pharmaceuticals Co Ltd banner

Wall St Price Targets

JCR Price Forecast
Based on 10 analysts

+23% Upside
from €2.94 today

JCR Pharmaceuticals Co Ltd (JCR)’s 12-month stock price forecast through October 2027 has a consensus target of €3.62, implying 23% upside. The forecast is based on price targets from 10 Wall Street analysts.

JCR Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for JCR yet.

JCR Pharmaceuticals Co Ltd Competitors:
Price Targets

Financial forecasts

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is JCR's stock price target?
Price Target
3.62 EUR

According to Wall Street analysts, the average 1-year price target for JCR is 3.62 EUR with a low forecast of 2.99 EUR and a high forecast of 6.21 EUR.

What is the Revenue forecast for JCR Pharmaceuticals Co Ltd?
Projected CAGR
3%

Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is 3%.

What is the Gross Profit forecast for JCR Pharmaceuticals Co Ltd?
Projected CAGR
3%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 3 years is 3%.

What is the Pre-Tax Income forecast for JCR Pharmaceuticals Co Ltd?
Projected CAGR
200%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 9%. The projected CAGR for the next 3 years is 200%.

What is the Net Income forecast for JCR Pharmaceuticals Co Ltd?
Projected CAGR
212%

Over the last 13 years, the compound annual growth rate for Net Income has been 9%. The projected CAGR for the next 3 years is 212%.

Back to Top